Advertisement
Essay

Essay Essays are opinion pieces on a topic of broad interest to a general medical audience.

See all article types »

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

  • David W. Dowdy mail,

    ddowdy@jhsph.edu

    Affiliation: Department of Medicine, University of California, San Francisco, California, United States of America

    Current address: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

    X
  • Adithya Cattamanchi,

    Affiliation: Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, California, United States of America

    X
  • Karen R. Steingart,

    Affiliation: Curry International Tuberculosis Center, San Francisco, California, United States of America

    X
  • Madhukar Pai

    Affiliation: Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada

    X
  • Published: July 26, 2011
  • DOI: 10.1371/journal.pmed.1001063

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Speed and Convenience Aren't Everything with Diagnostics

Editorial | published 25 Oct 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001113

Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective Study

Lesley E. Scott, Kerrigan McCarthy, Natasha Gous, Matilda Nduna, Annelies Van Rie, Ian Sanne, Willem F. Venter, Adrian Duse, Wendy Stevens
Research Article | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001061

GeneXpert—A Game-Changer for Tuberculosis Control?

Carlton A. Evans
Perspective | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001064

Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study

Stephen D. Lawn, Sophie V. Brooks, Katharina Kranzer, Mark P. Nicol, Andrew Whitelaw, Monica Vogt, Linda-Gail Bekker, Robin Wood
Research Article | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001067

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

David W. Dowdy, Adithya Cattamanchi, Karen R. Steingart, Madhukar Pai
Essay | published 26 Jul 2011 | PLOS Medicine
doi:10.1371/journal.pmed.1001063